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INTRODUCTION:  Port-site  metastasis  of cervical  cancer  is  a relatively  rare  occurrence,  and  has  been
reported  in  the  published  literature  as a pre-terminal  event.
PRESENTATION  OF  CASE:  We  present  the case  of  a 52-year-old  female  who  was  diagnosed  with  cervical
cancer  after  presenting  to  our  institution’s  hospital  with  urinary  symptoms  not  relieved  by  multiple  treat-
ments  with  antibiotics.  To fully  evaluate  the  extent  of  disease,  positron  emission  tomography-computed
tomography  imaging  was obtained,  showing  an  area  of  mildly  increased  ﬂuorodeoxyglucose  uptake  in  her
umbilicus.  While  undergoing  external-beam  radiotherapy  treatment  for her  cervical  cancer,  she  began
to experience  pain  in the  umbilicus  associated  with  a mass.  A biopsy  was  taken,  revealing  metastatic  cer-
vical  cancer  at  the  site of a previous  port-site  incision  for a cholecystectomy  that  the patient  underwent
18  months  before  the  ﬁnding.
DISCUSSION:  Port-site  metastasis  have  been  reported  following  kidney,  bladder,  and colon  cancer  resec-
tions,  with  reports  of  cervical  cancer  cases  being  exceedingly  rare.  Several  hypotheses  have  emerged  as
potential  explanations  for port-site  metastasis.
CONCLUSION:  To  our  knowledge,  this  represents  the  ﬁrst reported  case  of  a port-site  metastasis  to  an
incision site created  for  an  unrelated  laparoscopic  surgery,  performed  well  in advance  of the diagnosis  of
cervical  cancer.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
In developed countries, cervical cancer is the eleventh most
ommon type of cancer in women, and ninth most common cause of
ancer mortality [1]. Cervical cancer usually spreads through direct
nvasion of the surrounding anatomical structures or through the
ymphatics and circulatory system. Hematogenous spread typically
esults in metastasis to the bones, lungs, and liver, while lymphatic
pread travels ﬁrst to the iliac, obturator, and then parametrial
ymph nodes [2,3].
Imachi et al. reported a mean interval time between diagnosis of
ervical cancer and discovery of skin metastasis of 16.9 months [4],
ith skin metastasis becoming more likely as the stage of cervical
ancer increases [5]. Cutaneous metastasis from cervical cancer has
reviously been reported as a preterminal event, with a time of
iagnosis to death of 3 months [6].
. Presentation of caseA 52-year-old female was presented to our hospital’s
mergency department with a 6-week history of urinary incon-
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tinence, difﬁculty in initiating urination, and rectal pressure. She
was previously treated with ciproﬂoxacin as an outpatient, but,
despite treatment, her symptoms did not improve. On speculum
examination, it appeared that the cervix was replaced with an exo-
phytic tumor; on a subsequent speculum examination, the cervix
measured about 6 cm with bilateral parametrial thickening.
A computed tomography (CT) scan of the abdomen and pelvis
with intravenous contrast was  obtained and showed a 5.8 × 5.7-
cm enhancing mass in the cervix with involvement of the left
parametrium and left ureter, causing mild hydronephrosis, with
2 left external iliac pathologic lymph nodes (Fig. 1). A papanicolaou
test was also performed, revealing HPV 16 positivity, and, once dis-
charged from the emergency department, an ectocervical biopsy
was performed showing moderately differentiated invasive squa-
mous cell carcinoma of the cervix (Fig. 2). This malignancy was
determined to be stage IIIB T3b N1 M0  HPV-positive squamous cell
carcinoma of the cervix. The patient underwent a positron emission
tomography (PET)-CT in her staging workup that also demonstrated
a focus of increased ﬂuorodeoxyglucose uptake in the umbili-
cus. The radiologist noted it corresponded to an area of umbilical
thickening measuring 2 cm (Fig. 3). They noted it may represent
granulation tissue, previous infection, or even a tumor implant,
though the latter seemed less likely. Correlation with history was
recommended. Further questioning of the patient revealed that
she previously had her gallbladder removed through the umbili-
cus; thus it was suggested that this was inﬂammation from scar
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. The patient’s pretreatment computed tomography (CT) scan. The top two  images show the primary cervical mass. The bottom two images demonstrate the left
external iliac lymphadenopathy.
Fig. 2. (A) This histological section of the cervical tumor shows nests of inﬁltrating poorly-differentiated carcinoma cells with pleomorphic nuclei and cleared-out cytoplasm.
Abundant mitoses and individual cell tumor necrosis is also noted. (B) The tumors cells were strongly and diffusely positive for the surrogate HPV marker, p16INK4a, as
demonstrated by nuclear and cytoplasmic staining.
Fig. 3. These images demonstrate the positron emission tomography (PET) positivity of the umbilical mass in the anterior abdominal wall. The left one is the axial slice and
the  right one is the sagittal reconstruction.
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Fig. 4. (A) A representative histological section of the umbilical mass shows nests of
carcinoma cells embedded in a dense ﬁbrous stroma. These cells are morphologically
identical to the cells of the primary cervical tumor (Fig. 2A). (B) Immunohisto-CASE  REPORT
0 S. Kharod et al. / International Journ
issue. The patient was evaluated by our department, and a plan
as created to treat the entire pelvis with 45 Gy at 1.8 Gy/fraction,
ith a boost to the bilateral side walls and radiographically posi-
ive nodes to a total dose of 61.2 Gy over 34 fractions. She would be
e-assessed for a brachytherapy boost after the fourth week of radi-
tion. Also, she would undergo concurrent treatment with cisplatin
ith curative intent.
Four weeks after starting external-beam radiation therapy,
he patient began experiencing periumbilical pain, which she
ttributed to a hernia. Due to the concerning ﬁnding on the pre-
ious PET scan showing uptake in the umbilicus, her case was
resented at our gynecologic oncology tumor board. The consensus
ecision was to surgically remove this mass. A 3-cm nodule under
he umbilicus involving the fascia was removed, and pathology
evealed metastatic carcinoma consistent with poorly differenti-
ted squamous carcinoma (Fig. 4). The entire specimen was sent for
valuation of the margins and the tumor was found to involve the
nked deep margin. Immunohistochemistry was also performed to
onﬁrm the diagnosis and results showed the tumor was diffusely
uclear positive for p63 and strong nuclear and cytoplasmic posi-
ivity for p16, consistent with metastatic squamous cell carcinoma
f cervical origin.
This resulted in up-staging of the cervical cancer to stage IVB T4b
1 M1,  but she was already at the end of her deﬁnitive chemother-
py and radiation therapy, which she completed. The umbilical
ass was found to be at the site of a healed incision from a
aparoscopic cholecystectomy, performed 18 months earlier, for
reatment of symptomatic gallstones.
. Discussion
After discussing this patient’s case, it was agreed upon that the
mbilical metastasis was a result of the prior cholecystectomy and
hat her cervical cancer seeded in this site. The ﬁrst report, to our
nowledge, of port-site metastasis following a laparoscopic surgery
escribes a patient with malignant ascites who developed port-site
etastasis 2 weeks after undergoing surgery [7]; the report led to
oncern about whether laparoscopic surgery was  appropriate for
ncologic surgeries. It has subsequently been found that port-site
etastases are most commonly seen in laparoscopic surgeries for
reatment of kidney, bladder, and colon cancers [8]. Zivanovic et al.
n 2008 reported that of 1694 patients undergoing laparoscopic
rocedures for the treatment of intraabdominal malignancies, 20
atients (1.18%) experienced trochar-related subcutaneous tumor
mplants [9].
Cervical cancer port-site metastasis is very rare. In 1994,
hilders et al. reported their institution’s abdominal-wall tumor
mplantation rate after laparoscopic surgeries for gynecologic
alignancies, and found that no patients with cervical cancer
eveloped a tumor implantation in the incision site [10]. A 2004 ret-
ospective analysis of subcutaneous tumor implantation following
aparoscopic surgeries found that there were no isolated cases of a
ervical cancer trochar-related metastasis, and that all of the sub-
utaneous tumor implantations (13 patients, 0.97% of all patients)
ccurred with either carcinomatosis, synchronous metastases to
ther sites, or in the setting of a previous laparoscopic surgery in
he presence of malignancy in the abdomen and pelvis [11]. In a
005, retrospective analysis Chen et al. found that 1 patient (0.3%)
f 295 who underwent laparoscopic radical hysterectomy and lym-
hadenectomy for the treatment of cervical cancer experienced a
ort-site metastasis [12].
Several possible mechanisms of the development of port-site
etastasis have been previously described for cases in which
etastasis occurs following surgery for treatment of the primary
isease. Kohlberger et al. described the “chimney effect” as achemical studies using p63 demonstrate that the malignant cells are squamous in
origin. (C) A positive p16ink4a immunostain further reveals that the malignant cells
originate from the cervical primary.
possible explanation, in which case tumor cells that have been dis-
lodged from the cervix during surgery can rise to the port site due to
pneumoperitoneum [13]. Kadar postulated that a cause of port-site
metastasis is that tissue early in the state of healing is more con-
ducive to tumor growth and development than fully healed and
normal tissue, and that direct inoculation of the wound is neces-
sary to sustained tumor growth [14]. Gregor et al. suggested that
port-site metastasis was  related to port-site incision irritation and
spillage of tumor cells [16].
In a retrospective review of 24 patients with metastatic pri-
mary and recurrent gynecologic cancers, Kadar previously reported
that 2 women (8%) with metastatic cervical cancer developed
a port-site metastasis [14]. The 2 women  who experienced the
port-site metastasis did not have their trochar sites treated with
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ostoperative radiation or chemotherapy, a factor that was found
o be statistically signiﬁcant in reducing the rate of port-site metas-
ases. A 2013 review article by Freitas and Barbosa describes
echnical surgical methods that could reduce the rate of port-site
etastases, including minimal tumor manipulation, resection of
he tumor with adequate margins, peritoneal lavage with heparin
o avoid adhesions of free cells, use of protective bags for tissue
etrieval, avoidance of CO2 leaks or sudden desufﬂation, exsuf-
ation of the peritoneum prior to removal of ports, irrigation of
orts with heparin solution, and administration of systemic or
ntraperitoneal methotrexate [15].
. Conclusion
The case of our patient is quite unusual given that the port-site
etastasis occurred at the healed incision of an unrelated surgery
laparoscopic cholecystectomy) conducted 18 months before the
iagnosis of cervical cancer. The published literature on cervical
ort-site metastasis, to the best of our knowledge, solely describes
ases of port-site metastasis following surgery for treatment of a
ewly diagnosed cervical cancer. In our case, the patient did not
ndergo any other operations in the interval between the chole-
ystectomy and the removal of the incisional metastatic lesion. If
he above-mentioned theories about port-site metastases are to be
pplied to our case, it must be assumed that microscopic disease
ecame implanted in the umbilical incision site at the time of the
holecystectomy, which would make this case an extraordinarily
are occurrence.
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